Who invested in Senti Biosciences?
Senti Biosciences's investors include Menlo Ventures, Lux Capital, Pear VC, Gaingels and 8VC, and 14 more on record.

United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$169Mraised across 4 rounds since 2018, from 4 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Source recordedSEC filing: $10M sold
Reported by Firms' own news pages
Reported by FinSMEsSEC filing: $39M sold, first sale Feb 2018
From Senti Biosciences's own website: 4 on the team.
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Senti Biosciences's investors include Menlo Ventures, Lux Capital, Pear VC, Gaingels and 8VC, and 14 more on record.
Senti Biosciences has raised $169M across 4 rounds since 2018.
Senti Biosciences's most recent round was a Debt of $10M in May 2026.
Senti Biosciences's largest round on record is $105M (Series B), in Jan 2021, led by Leaps by Bayer.
Senti Biosciences's first round on record, in Feb 2018, was backed by Menlo Ventures, Lux Capital and Pear VC and 7 others.
Senti Biosciences's latest named round is a Debt, in May 2026.
Senti Biosciences is based in the United States.
Leaps by Bayer led the Series B in 2021.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.